Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives

查看全文 作　　者：Antonio [1,2]Pellino;Erika [1,3]Riello;Floriana [1,2]Nappo;Stefano [1,3]Brignola;Sabina [1]Murgioni;Selma Ahcene [1]Djaballah;Sara [1]Lonardi;Vittorina [1]Zagonel;Massimo [4]Rugge;Fotios [1]Loupakis;Matteo [3]Fassan

机构地区：[1]Department of Oncology,Veneto Institute of Oncology IOV-IRCCS,Padua 35100,Italy;[2]Department of Surgery,Oncology and Gastroenterology,University of Padua,Padua 35100,Italy;[3]Surgical Pathology&Cytopathology Unit,Department of Medicine,University of Padua,Padua 35100,Italy;[4]Veneto Cancer Registry,Padua 35100,Italy

出　　处：《World Journal of Gastroenterology》索引2019年第25卷第38期,共16页

摘　　要：Gastric cancer(GC)represents a leading cause of cancer related morbidity and mortality worldwide accounting for more than 1 million of newly diagnosed cases and thousands of deaths every year.In the last decade,the development of targeted therapies and the optimization of already available chemotherapeutic drugs has expanded the available treatment options for advanced GC and granted better survival expectations to the patients.At the same time,global efforts have been undertaken to investigate in detail the genomic and epigenomic heterogeneity of this disease,resulting in the identification of new specific and sensitive predictive and prognostic biomarkers and in innovative molecular classifications based on gene expression profiling.Nonetheless,several randomized studies aimed at exploring new innovative agents,such as immune checkpoint inhibitors,failed to demonstrate clinically meaningful survival advantages.Therefore,it is essential to further improve the molecular characterization of GC subgroups in order to provide researchers and medical oncologists with new tools for patients’selection and stratification in future clinical development programs and subsequent trials.The aim of the present manuscript is to provide a global overview of the recent molecular classifications from The Cancer Genome Atlas and the Asian Cancer Research Group and to present key promising developments in the field of immunotherapy and targeted therapies in metastatic GC. 关键词：GASTRIC CANCER PERSONALIZED medicine PREDICTIVE biomarkers Molecular diagnostic The CANCER GENOME ATLAS Asian CANCER Research Group

相关文献

参考文献（87）
引证文献（16）
耦合文献（0）

参考文献(87)

引证文献(16)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives

参考文献(87)

引证文献(16)

用户提示